DESIGN OF GASTRORETENTIVE POLYMERIC LOW-DENSITY MICROBALLOONS OF MEBENDAZOLE USING RESPONSE SURFACE METHODOLOGY

JEEVANA JYOTHI B; SOWMYA M

doi:10.22159/ajpcr.2022.v15i7.44090

Authors

JEEVANA JYOTHI B Department of Pharmaceutics, Sri Padmavati Mahila Visvavidyalayam (Women’s University), Tirupati, Andhra Pradesh, India. https://orcid.org/0000-0002-8954-2409
SOWMYA M Department of Pharmaceutics, Sri Padmavati Mahila Visvavidyalayam (Women’s University), Tirupati, Andhra Pradesh, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i7.44090

Keywords:

Microballoons, Mebendazole, Emulsion solvent diffusion, Response surface methodology

Abstract

Objective: The main objective of the present work is the development of polymeric low-density microballoons for prolonged gastroretentive delivery and optimization of promising formulation by central composite design of response surface methodology.

Methods: Mebendazole-loaded microballoons were prepared by emulsion solvent diffusion method using Eudragit S-100 and hydroxypropyl methylcellulose as release controlling polymers. All the formulations of mebendazole-loaded microballoons showed buoyancy up to 8 h. Percentage of Eudragit S-100 (X1) in total amount of polymer and solvent ratio (X2) was taken as two independent variables. The responses are evaluated to study the effect of independent variables and the optimum formulation was chosen based on numerical and graphical optimization.

Results: The optimized formulation MBZ9 was composed of 100 mg of mebendazole, 75% of Eudragit S-100, and 25% of HPMC with DCM: ETH ratio of 1:1. The optimized formulation showed yield (81%), buoyancy (86.4%), entrapment efficiency (82.01%), and cumulative drug release for 12 h (79.99%). The optimized formulation was characterized by differential scanning calorimetry, and Fourier-transform infrared spectroscopy. It followed mixed order and the mechanism of drug release was diffusion as per R2=0.905 in Higuchi model.

Conclusion: Microballoons of mebendazole produced with 75% Eudragit S-100, X1 (750 mg), 25% of HPMC polymer, and 1:1 DCM: ETH solvent ratio X2 (10:10 ml) optimized by response surface methodology are successful with enhanced gastroretentive effect and controlled release to elicit promising anthelminthic effect in the gastrointestinal tract.

Downloads

Download data is not yet available.

References

Kanupriya C, Seth N, Gill N. Gastro retentive drug delivery system: A significant tool to increase the gastric residence time of drugs. Int J Curr Pharm Res 2021;15:7-11.

Hajare PP, Rachh PR. Gastroretentivemicroballoons: A novel approach for drug delivery. Int J Pharm Sci Res 2020;11:1075-83.

Son DS, Lee ES, Adunyah SE. The antitumor potentials of benzimidazoleanthelmintics as repurposing drugs. Immune Network 2020;20:e29. doi: 10.4110/in.2020.20.e29, PMID 32895616

Giri TK, Verma S, Alexander A, Badwaik H, Tripathi DK. Prospective and new findings of hydroxypropyl methylcellulose (HPMC) as a potential carrier for gastrorententive drug delivery systems. Drug Deliv Lett 2012;2:98-107.

Arafat M. Approaches to achieve an oral controlled release drug delivery system using polymers: A recent review. Int J Pharm Pharm Sci 2015;7:16-21.

Blehn GF, Ernsberger ML. Polyvinyl alcohol as an emulsifying agent. Ind Eng Chem 1948;40:1449-53. doi: 10.1021/ie50464a024

Kadian SS, Harikumar S. Eudragit and its pharmaceutical significance. Eudragit Pharm Signif 2009:1-16.

Ramteke KH, Jadhav VB, Kulkarni NS, Kharat AR, Diwate SB. Preparation, evaluation and optimization of multiparticulate system of mebendazole for colon targeted drug delivery by using natural polysaccharides. Adv Pharm Bull 2015;5:361-71. doi: 10.15171/ apb.2015.050, PMID 26504758

Huang YB, Tsai YH, Yang WC, Chang JS, Wu PC, Takayama K. Once-daily propranolol extended-release tablet dosage form: Formulation design and in vitro/in vivo investigation. Eur J Pharm Biopharm 2004;58:607-14. doi: 10.1016/j.ejpb.2004.03.037, PMID 15451535

Ammar HO, Ghorab M, Kamel R, Salama AH. Design and optimization of gastro-retentive microballoons for enhanced bioavailability of cinnarizine. Drug Deliv Transl Res 2016;6:210-24. doi: 10.1007/ s13346-016-0280-4, PMID 26832133

Doniparthi J, Jyothi BJ. Novel tamarind seed gum-alginate based multi-particulates for sustained release of dalfampridine using response surface methodology. Int J Biol Macromol 2020;144:725-41. doi: 10.1016/j.ijbiomac.2019.11.203, PMID 31843610

Kuldeep HR, Varsha BJ, Nilesh SK, Amol RK, Sonali BD. Preparation, evaluation and optimization of multiparticulate system of mebendazole for colon targeted drug delivery by using natural polysaccharides. Adv Pharm Bulletein 2015;5:361-71.

Choudhary S, Jain A, Amin MC, Mishra V, Agrawal GP, Kesharwani P. Stomach specific polymeric low density microballoons as a vector for extended delivery of rabeprazole and amoxicillin for treatment of peptic ulcer. Colloids Surf B Biointerfaces 2016;141:268-77. doi: 10.1016/j. colsurfb.2016.01.048, PMID 26859118

Mastiholimath VS, Dandagi PM, Gadad AP, Mathews R, Kulkarni AR. In vitro and in vivo evaluation of ranitidine hydrochloride ethyl cellulose floating microparticles. J Microencapsul 2008;25:307-14. doi: 10.1080/02652040801973101, PMID 18465300

Awasthi R, Kulkarni GT. Development and characterization of amoxicillin loaded floating microballoons for the treatment of Helicobacter pylori induced gastric ulcer. Asian J Pharm Sci 2013;8:174-80. doi: 10.1016/j.ajps.2013.07.023

Nila MV, Sudhir MR, Cinu TA, Aleykutty NA, Jose S. Floating microspheres of carvedilol as gastro retentive drug delivery system: 32 full factorial design and in vitro evaluation. Drug Deliv 2014;21:110-7. doi: 10.3109/10717544.2013.834414, PMID 24028280